The North America Veterinary Dermatology Drugs Market is expected to witness market growth of 7.4% CAGR during the forecast period (2021-2027).
Currently, over one-fifth of all animal veterinary meetings are related to dermatological issues. Conditions such as allergies, seborrhoeic dermatitis, otitis externa, and surface pyoderma are some of the commonly diagnosed dermatological conditions. The veterinary dermatology market is still demanding massive improvements in the animal dermatology industry and thus, there is a development in innovating new drugs for the veterinary service.
With the development in the safety and efficacy studies, there have been significant developments made for equine lameness and the makers are willing to boost production capabilities and distribution of the drugs, thereby assisting horses around the world. In the last few years, constant developments in equine dermatological drugs are assisting in treating common diseases like fungal infection, skin inflammation, or an infectious bacterium in horses. The demand for veterinary dermatology drugs is expected to be driven by the fact that the prevalence of diseases in horses is very high around the globe.
North America emerged as the dominant region in the overall veterinary dermatology drugs market and is expected to showcase a similar kind of trend during the forecasting period. The growth of the regional market includes the higher adoption rate of companion animals in well-established nations like Canada, US, and higher expenditure on pet care in this region. According to the American Pet Products Association (APPA) data reveals that 68% of US households, or around 86.4 million homes, have a minimum of one pet.
Conversely, the growth of the regional market is expected to further be driven by the massive prevalence of pruritus, alopecia, sores, masses, pustules, scales, eruptions, seborrhea, and draining tracts in companion animals. Moreover, a key driver for the regional market is the surge in technology in veterinary medicine that has expanded the lifespan of veterinary animals.
The US market dominated the North America Oral Market by Country 2020, and is expected to continue to be a dominant market till 2027; thereby, achieving a market value of $1,354.1 million by 2027. The Canada market is experiencing a CAGR of 9.1% during (2021 - 2027). Additionally, The Mexico market is expected to witness a CAGR of 8.1% during (2021 - 2027).
Based on Route of Administration, the market is segmented into Topical, Injectable and Oral. Based on Distribution Channel, the market is segmented into Retail, Hospital Pharmacies and Online. Based on Drug Indication, the market is segmented into Parasitic Infections, Allergic Infections and Other Indications. Based on Animal Type, the market is segmented into Companion Animal and Livestock Animal. Based on countries, the market is segmented into U.S., Mexico, Canada, and Rest of North America.
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Merck Group, Elanco Animal Health, Inc., Zoetis, Inc., Eli Lilly and Company, Boehringer Ingelheim International GmbH, Vetoquinol SA (Soparfin SCA), Virbac, Bioibérica, S.A.U., Bimeda, Inc., and Ceva Santé Animale.
Scope of the Study
Market Segments Covered in the Report:
By Route of Administration
- Topical
- Injectable
- Oral
By Distribution Channel
- Retail
- Hospital Pharmacies
- Online
By Drug Indication
- Parasitic Infections
- Allergic Infections
- Other Indications
By Animal Type
- Companion Animal
- Livestock Animal
By Country
- US
- Canada
- Mexico
- Rest of North America
Key Market Players
List of Companies Profiled in the Report:
- Merck Group
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Vetoquinol SA (Soparfin SCA)
- Virbac
- Bioibérica, S.A.U.
- Bimeda, Inc.
- Ceva Santé Animale
Unique Offerings from the Publisher
- Exhaustive coverage
- The highest number of market tables and figures
- Subscription-based model available
- Guaranteed best price
- Assured post sales research support with 10% customization free
Table of Contents
Companies Mentioned
- Merck Group
- Elanco Animal Health, Inc.
- Zoetis, Inc.
- Eli Lilly and Company
- Boehringer Ingelheim International GmbH
- Vetoquinol SA (Soparfin SCA)
- Virbac
- Bioibérica, S.A.U.
- Bimeda, Inc.
- Ceva Santé Animale
Methodology
LOADING...
